MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 17, 2025

Date Posted: July 3, 2025

The following MolDX Local Coverage Determinations (LCDs) have completed the Open Public Meeting comment period and are now finalized under contractor numbers: 01112 (NCA), 01182 (SCA), 01212 (AS, GU, HI, and NMI), and 01312 (NV).

Medicare Coverage Database Number MolDX LCD Title
L39944 MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
L39948 MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
L39923 MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
MCD Number MolDX Billing and Coding Article Title
A59868 Billing and Coding: MolDX: Genetic Testing in Heritable Thoracic Aortic Disease
A59872 Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A59835 Billing and Coding: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms
Medicare Coverage Database Number Response to Comments
A60206 Response to Comments: MolDX: Genetic Testing for Heritable Thoracic Aortic Disease
A60201 Response to Comments: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A60227 Response to Comments: MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms

Effective Date: August 17, 2025

View Active MolDX LCDs on our website or the CMS MCD.

Last Updated $dateUtil.getDate( $modifieddate , "MMM dd , yyyy" , $locale , $tzone )